# Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

> **NCT00322621** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 216 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT00322621
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2011-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322621, "Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00322621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*